SDC1 and hepatocellular carcinoma: The proliferation rate of truncated syndecan-1 transfectants decreased significantly in both hepatoma cell lines (Student’ t-test, HepG2 p < 0.001 and Hep3B p < 0.001) (Figure 5A,B).